Cornerstone Capital Inc. Sells 69 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cornerstone Capital Inc. lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,625 shares of the medical equipment provider’s stock after selling 69 shares during the period. Cornerstone Capital Inc.’s holdings in Intuitive Surgical were worth $6,590,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the company. Bennett Selby Investments LP increased its stake in Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after buying an additional 17 shares during the period. Onefund LLC increased its holdings in Intuitive Surgical by 1.9% in the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock worth $494,000 after buying an additional 18 shares during the last quarter. LVW Advisors LLC raised its position in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after acquiring an additional 19 shares in the last quarter. Wesbanco Bank Inc. grew its position in Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after acquiring an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC raised its holdings in shares of Intuitive Surgical by 1.9% during the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock valued at $542,000 after purchasing an additional 19 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at $2,793,033.06. The trade was a 60.72 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 33,754 shares of company stock worth $17,691,621. 0.70% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Leerink Partners upped their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Robert W. Baird dropped their price objective on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research note on Tuesday, March 18th. Truist Financial reduced their price target on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a research report on Monday, March 17th. Piper Sandler restated an “overweight” rating and set a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Finally, Royal Bank of Canada upped their price objective on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $611.81.

Intuitive Surgical Trading Up 0.3 %

NASDAQ ISRG opened at $482.74 on Friday. The stock has a market cap of $171.94 billion, a price-to-earnings ratio of 75.31, a PEG ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company’s 50 day moving average is $522.23 and its two-hundred day moving average is $532.02.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.